Article
Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Clinical and experimental rheumatology - 1 Jan 2000
Milic Vera, Jekic Biljana, Lukovic Ljiljana, Bunjevacki Vera, Milasin Jelena, Novakovic Ivana, Damnjanovic Tatjana, Popovic Branka, Maksimovic Nela, Damjanov Nemanja, Radunovic Goran, Pejnovic Nada, Krajinovic Maja
Abstract excerpt
OBJECTIVES: Identifying genetic predictors of methotrexate (MTX) treatment response in patients with rheumatoid arthritis (RA) may have great importance for optimising drug doses required for clinical benefit without toxicity. In a group of 125 RA patients treated with MTX we investigated whether selected polymorphisms in genes relevant for MTX action (aminoimidazole-4-carboxiamide ribonucleotide transformylase,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
